Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Head and Neck Cancer

  Free Subscription


Articles published in Gastrointest Endosc

Retrieve available abstracts of 103 articles:
HTML format



Single Articles


    April 2024
  1. POCCI M, Alfieri R, Fassan M, Realdon S, et al
    Buried esophageal adenocarcinoma after radiofrequency ablation with pagetoid spreading.
    Gastrointest Endosc. 2024;99:642-643.
    PubMed    


    March 2024
  2. HABER G
    What goes around, comes around: circumferential endoscopic submucosal dissection and stricture.
    Gastrointest Endosc. 2024;99:346-348.
    PubMed    


  3. XIANG AY, Wang KH, Su W, Tan T, et al
    Endoscopic resection of giant esophageal subepithelial lesions: experience from a large tertiary center.
    Gastrointest Endosc. 2024;99:358-370.
    PubMed     Abstract available


  4. MOTOMURA D, Bechara R
    Complete circumferential endoscopic submucosal dissection for early Barrett's neoplasia.
    Gastrointest Endosc. 2024;99:337-345.
    PubMed     Abstract available


    February 2024
  5. SUNAKAWA H, Yoda Y, Nonaka S, Suzuki H, et al
    Prospective multicenter trial of the cryoballoon ablation system for superficial esophageal squamous cell carcinoma on the post-endoscopic resection scar. A CRYO-SCAR study (EPOC1902).
    Gastrointest Endosc. 2024 Feb 29:S0016-5107(24)00134.
    PubMed     Abstract available


  6. KOGGEL LM, Reijm AN, Lantinga MA, de Jong DJ, et al
    Multisegmented esophageal fully covered self-expandable metal stent for palliation of malignant dysphagia: a prospective multicenter feasibility and safety study.
    Gastrointest Endosc. 2024 Feb 3:S0016-5107(24)00089.
    PubMed     Abstract available


  7. DI L, Wu X, Tuo B
    A case of rare early type 0-IIb esophageal adenoid cystic carcinoma accompanied by squamous cell carcinoma.
    Gastrointest Endosc. 2024;99:280-281.
    PubMed    


    December 2023
  8. YU S, Wang Y, Zhang Q
    A special esophageal carcinoma: both dual neoplasms and concurrent 3-type mixed esophageal carcinoma diagnosed by endoscopic submucosal dissection.
    Gastrointest Endosc. 2023;98:1023-1024.
    PubMed    


  9. LADD AM, Park K, Bilal M, Schlachterman A, et al
    Prophylactic stenting to decrease the incidence of esophageal strictures after extensive endoscopic submucosal dissection: the first U.S. experience.
    Gastrointest Endosc. 2023;98:1000-1003.
    PubMed    


  10. LI J, Yu L, Sun H, Ye L, et al
    Endoscopic submucosal dissection for a giant fibrovascular polyp in the esophagus.
    Gastrointest Endosc. 2023;98:1024-1025.
    PubMed    


    November 2023
  11. JOSEPH A, Vantanasiri K, Draganov PV, King W, et al
    ENDOSCOPIC SUBMUCOSAL DISSECTION WITH VERSUS WITHOUT TRACTION FOR PATHOLOGICALLY STAGED T1B ESOPHAGEAL CANCER: A MULTICENTER RETROSPECTIVE STUDY.
    Gastrointest Endosc. 2023 Nov 30:S0016-5107(23)03123.
    PubMed     Abstract available


  12. KAWAMATA N, Shimamura Y, Tanaka I, Inoue H, et al
    Enhancing Diagnosis: The role of endocytoscopy in diagnosing small esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2023 Nov 23:S0016-5107(23)03099.
    PubMed    


  13. LIN YX, Liu W, Yuan XL, Hu B, et al
    Endoscopic submucosal dissection for the treatment of advanced esophageal cancer subsequent to chemotherapy.
    Gastrointest Endosc. 2023 Nov 21:S0016-5107(23)03105.
    PubMed    


  14. YOSHIZAKI T, Yamamoto Y, Sako T, Kitamura Y, et al
    Outcomes of endoscopic submucosal dissection for esophageal cancer with segmental absence of intestinal musculature.
    Gastrointest Endosc. 2023 Nov 10:S0016-5107(23)03043.
    PubMed     Abstract available


  15. BURTON SJ, Muniraj T
    Advancing surveillance protocols for dysplastic Barrett's esophagus after complete remission of intestinal metaplasia: Time to rethink biopsy strategy?
    Gastrointest Endosc. 2023;98:733-734.
    PubMed    


    October 2023
  16. RODRIGUEZ DE SANTIAGO E, van Tilburg L, Deprez PH, Pioche M, et al
    Western outcomes of circumferential endoscopic submucosal dissection for early esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2023 Oct 23:S0016-5107(23)02997.
    PubMed     Abstract available


  17. QIU XO, Jiang X, Chen YZ, Xia JS, et al
    New US capsule endoscopy for superficial and submucosal imaging of the esophagus: the first-in-human study.
    Gastrointest Endosc. 2023;98:642-652.
    PubMed     Abstract available


  18. GENG ZH, Zhu Y, Li QL, Fu PY, et al
    Muscular injury as an independent risk factor for esophageal stenosis after endoscopic submucosal dissection of esophageal squamous cell cancer.
    Gastrointest Endosc. 2023;98:534-542.
    PubMed     Abstract available


  19. OGASAWARA N, Kikuchi D, Tanaka M, Ochiai Y, et al
    Long-term outcome of cervical lymph node metastasis in superficial pharyngeal squamous cell carcinoma after endoscopic submucosal dissection.
    Gastrointest Endosc. 2023;98:524-533.
    PubMed     Abstract available


    September 2023
  20. TRINDADE AJ, Odze RD, Smith MS, Kaul V, et al
    Benefit of adjunctive wide-area transepithelial sampling with 3-dimensional computer-assisted analysis plus forceps biopsy based on Barrett's esophagus segment length.
    Gastrointest Endosc. 2023;98:316-325.
    PubMed     Abstract available


    August 2023
  21. ABE S, Kadota T, Saito Y
    Prediction of postendoscopic submucosal dissection esophageal stricture: Do we no longer need a protractor?
    Gastrointest Endosc. 2023;98:178-180.
    PubMed    


  22. MIYAKE M, Ishihara R, Matsuura N, Ueda T, et al
    Predictors of stricture after non-circumferential endoscopic submucosal dissection of the esophagus and single-dose triamcinolone injection immediately after the procedure.
    Gastrointest Endosc. 2023;98:170-177.
    PubMed     Abstract available


  23. STEWART M, Menon A, Akbar U, Garg S, et al
    Missed opportunities to screen for Barrett's esophagus in the primary care setting of a large health system.
    Gastrointest Endosc. 2023;98:162-169.
    PubMed     Abstract available


  24. SINGH RR, Desai M, Bourke M, Falk G, et al
    Real-world evidence of safety and effectiveness of Barrett's endoscopic therapy.
    Gastrointest Endosc. 2023;98:155-161.
    PubMed     Abstract available


  25. SATO H, Hamada K, Abe M, Makino T, et al
    Application of the Valsalva maneuver to prevent adhesion and deformity after hypopharyngeal endoscopic submucosal dissection.
    Gastrointest Endosc. 2023;98:254-256.
    PubMed    


    July 2023
  26. FORBES N, Elhanafi SE, Al-Haddad MA, Thosani NC, et al
    American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations.
    Gastrointest Endosc. 2023 Jul 25:S0016-5107(23)00355.
    PubMed     Abstract available


  27. AL-HADDAD MA, Elhanafi SE, Forbes N, Thosani NC, et al
    American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidence.
    Gastrointest Endosc. 2023 Jul 25:S0016-5107(23)00371.
    PubMed     Abstract available


  28. LUO W, Zhang T
    The clinical outcomes of endoscopic submucosal dissection for superficial circumferential esophageal squamous cell carcinoma may be not as ideal as expected.
    Gastrointest Endosc. 2023;98:138.
    PubMed    


    June 2023
  29. GAO Y, Li ZS, Wang LW
    Concerns about pooled performances of cytology for esophageal squamous cell carcinoma screening.
    Gastrointest Endosc. 2023;97:1169.
    PubMed    


  30. BEYNA T
    Top tips for performing Barrett's ablation.
    Gastrointest Endosc. 2023;97:1137-1143.
    PubMed    


    May 2023
  31. DONG J, Dai Z, Cao F, Zhang W, et al
    Effects of Percutaneous Endoscopic Gastrostomy in Patients with Esophageal Squamous Cell Carcinoma During Concurrent Chemoradiotherapy: a Prospective Study.
    Gastrointest Endosc. 2023 May 5:S0016-5107(23)02508.
    PubMed     Abstract available


  32. DONG Y, Li B, He D, Zhong Y, et al
    Mediastinal Castleman disease diagnosed by transesophageal submucosal tunneling endoscopic resection.
    Gastrointest Endosc. 2023;97:985-986.
    PubMed    


    April 2023
  33. HUSSEIN M, Lines D, Gonzalez-Bueno Puyal J, Kader R, et al
    Computer-aided characterization of early cancer in Barrett's esophagus on i-scan magnification imaging: a multicenter international study.
    Gastrointest Endosc. 2023;97:646-654.
    PubMed     Abstract available


    March 2023
  34. CHUANG PL, Hsu WH, Wu IC
    Endoscopic submucosal dissection following definite chemoradiotherapy for advanced cervical esophageal cancer.
    Gastrointest Endosc. 2023 Mar 3:S0016-5107(23)00298.
    PubMed    


  35. ABDELRAHIM M, Saiko M, Maeda N, Hossain E, et al
    Development and validation of artificial neural networks model for detection of Barrett's neoplasia: a multicenter pragmatic nonrandomized trial (with video).
    Gastrointest Endosc. 2023;97:422-434.
    PubMed     Abstract available


  36. NEHME F, Ross W, Coronel E
    Spinal cord compression related to an esophageal self-expandable metal stent.
    Gastrointest Endosc. 2023;97:594-595.
    PubMed    


    February 2023
  37. PERISETTI A, Sharma P
    Tips for improving the identification of neoplastic visible lesions in Barrett's esophagus.
    Gastrointest Endosc. 2023;97:248-250.
    PubMed    


  38. BEVERIDGE CA, Mittal C, Muthusamy VR, Rastogi A, et al
    Identification of visible lesions during surveillance endoscopy for Barrett's esophagus: a video-based survey study.
    Gastrointest Endosc. 2023;97:241-247.
    PubMed     Abstract available


    December 2022
  39. YUAN XL, Zeng XH, Liu W, Mou Y, et al
    Artificial intelligence for detecting and delineating the extent of superficial esophageal squamous cell carcinoma and precancerous lesions under narrow band imaging.
    Gastrointest Endosc. 2022 Dec 9:S0016-5107(22)02204.
    PubMed     Abstract available


  40. MCDONALD OG, Montgomery EA
    Artificial intelligence for dysplasia grading in Barrett's esophagus: hematoxylin and eosin is here to stay.
    Gastrointest Endosc. 2022;96:926-928.
    PubMed    


  41. FAGHANI S, Codipilly DC, David Vogelsang, Moassefi M, et al
    Development of a deep learning model for the histologic diagnosis of dysplasia in Barrett's esophagus.
    Gastrointest Endosc. 2022;96:918-925.
    PubMed     Abstract available


    November 2022
  42. FREDERIKS CN, Overwater A, Alvarez Herrero L, Alkhalaf A, et al
    Comparison of focal cryoballoon ablation with 10- and 8-second doses for treatment of Barrett's esophagus-related neoplasia: results from a prospective European multicenter study (with video).
    Gastrointest Endosc. 2022;96:743-751.
    PubMed     Abstract available


    October 2022
  43. MINAMIDE T, Kawata N, Maeda Y, Yoshida M, et al
    Clinical outcomes of endoscopic submucosal dissection for superficial circumferential esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2022 Oct 10. pii: S0016-5107(22)02035.
    PubMed     Abstract available


    September 2022
  44. DENG K, Jing W, Chen M
    More prognostic information may be harvested in the subgroup analysis of esophageal adenocarcinoma unrelated death.
    Gastrointest Endosc. 2022;96:566.
    PubMed    


  45. FAN X, Wu Q, Li R, Chen W, et al
    Clinical benefit of tunnel endoscopic submucosal dissection for esophageal squamous cancer: a multicenter, randomized controlled trial.
    Gastrointest Endosc. 2022;96:436-444.
    PubMed     Abstract available


    August 2022
  46. KAMBOJ AK, Iyer PG
    Pushing the boundaries of endoscopic management of early-stage esophageal adenocarcinoma: Caution is advisable!
    Gastrointest Endosc. 2022;96:248-249.
    PubMed    


  47. VAN MUNSTER SN, Pouw RE
    Solving the puzzle of optimal surveillance after endoscopic eradication therapy of Barrett's esophagus.
    Gastrointest Endosc. 2022;96:234-236.
    PubMed    


  48. WONG MCS, Deng Y, Huang J, Bai Y, et al
    Performance of screening tests for esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Gastrointest Endosc. 2022;96:197-207.
    PubMed     Abstract available


  49. NIEUWENHUIS EA, van Munster SN, Meijer SL, Brosens LAA, et al
    Analysis of metastases rates during follow-up after endoscopic resection of early "high-risk" esophageal adenocarcinoma.
    Gastrointest Endosc. 2022;96:237-247.
    PubMed     Abstract available


  50. WOLFSON P, Ho KMA, Wilson A, McBain H, et al
    Endoscopic eradication therapy for Barrett's esophagus-related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry.
    Gastrointest Endosc. 2022;96:223-233.
    PubMed     Abstract available


    July 2022
  51. LIU K, Aadam AA
    T1b esophageal cancer: Is it time for endoscopic submucosal dissection to enter the stage?
    Gastrointest Endosc. 2022 Jul 18. pii: S0016-5107(22)01681.
    PubMed    


    June 2022
  52. CHAN MW, Pouw RE
    Risk-stratification models for Barrett's esophagus: Will we get to the perfect classifier?
    Gastrointest Endosc. 2022;95:1123-1125.
    PubMed    


  53. THOTA PN, Nasibli J, Kumar P, Sanaka MR, et al
    Prediction of neoplastic progression in Barrett's esophagus using nanoscale nuclear architecture mapping: a pilot study.
    Gastrointest Endosc. 2022;95:1239-1246.
    PubMed     Abstract available


  54. NGUYEN TH, Thrift AP, Ketwaroo GA, Du XL, et al
    External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans.
    Gastrointest Endosc. 2022;95:1113-1122.
    PubMed     Abstract available


  55. DEMEESTER S, Smith C, Severson P, Loveitt A, et al
    Multicenter randomized controlled trial comparing forceps biopsy sampling with wide-area transepithelial sampling brush for detecting intestinal metaplasia and dysplasia during routine upper endoscopy.
    Gastrointest Endosc. 2022;95:1101-1110.
    PubMed     Abstract available


    April 2022
  56. YANG D, King W, Aihara H, Karasik MS, et al
    Effect of endoscopic submucosal dissection on histologic diagnosis in Barrett's esophagus visible neoplasia.
    Gastrointest Endosc. 2022;95:626-633.
    PubMed     Abstract available


    March 2022
  57. CODIPILLY DC, Iyer PG
    What's next for wide-area transepithelial sampling in Barrett's esophagus management?
    Gastrointest Endosc. 2022;95:419-421.
    PubMed    


  58. AGARWAL S, Alshelleh M, Scott J, Dhaliwal L, et al
    Comparative outcomes of radiofrequency ablation and cryoballoon ablation in dysplastic Barrett's esophagus: a propensity score-matched cohort study.
    Gastrointest Endosc. 2022;95:422-431.
    PubMed     Abstract available


  59. SHAHEEN NJ, Smith MS, Odze RD
    Progression of Barrett's esophagus, crypt dysplasia, and low-grade dysplasia diagnosed by wide-area transepithelial sampling with 3-dimensional computer-assisted analysis: a retrospective analysis.
    Gastrointest Endosc. 2022;95:410-418.
    PubMed     Abstract available


    February 2022
  60. XU JQ, Zhang ZC, Chen WF, Xu MD, et al
    Repeated endoscopic submucosal dissection (ESD) as salvage treatment for local recurrence of esophageal squamous cell carcinoma after initial ESD.
    Gastrointest Endosc. 2022 Feb 28. pii: S0016-5107(22)00182.
    PubMed     Abstract available


  61. JOSEPH A, Draganov P, Maluf-Filho F, Aihara H, et al
    Outcomes for ESD of Pathologically Staged T1b Esophageal Cancer: A Multi-Center Study.
    Gastrointest Endosc. 2022 Feb 22. pii: S0016-5107(22)00123.
    PubMed     Abstract available


  62. HONING J, di Pietro M
    Surveillance for Barrett's esophagus: let's get the basics right.
    Gastrointest Endosc. 2022;95:246-248.
    PubMed    


  63. PARASA S, Wallace MB, Srinivasan S, Sundaram S, et al
    Educational intervention to improve quality of care in Barrett's esophagus: the AQUIRE randomized controlled trial.
    Gastrointest Endosc. 2022;95:239-245.
    PubMed     Abstract available


  64. GUO Q, Fan X, Zhu S, Zhao X, et al
    Comparing N-acetylcysteine with sodium thiosulfate for relieving symptoms caused by Lugol's iodine chromoendoscopy: a randomized, double-blind trial.
    Gastrointest Endosc. 2022;95:249-257.
    PubMed     Abstract available


    January 2022
  65. CODIPILLY DC, Krishna Chandar A, Wang KK, Katzka DA, et al
    Wide-area transepithelial sampling for dysplasia detection in Barrett's esophagus: a systematic review and meta-analysis.
    Gastrointest Endosc. 2022;95:51-59.
    PubMed     Abstract available


  66. ADLER DG
    Esophageal papillomatosis presenting with complete esophageal obstruction and high positron emission tomography avidity.
    Gastrointest Endosc. 2022;95:187-188.
    PubMed    


  67. FARHA N, Hrabe J, Sleiman J, Beard J, et al
    Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome.
    Gastrointest Endosc. 2022;95:105-114.
    PubMed     Abstract available


    December 2021
  68. TANAKA I, Hirasawa D, Matsuda T
    Extremely small but invasive esophageal cancer: endoscopists should not miss it.
    Gastrointest Endosc. 2021 Dec 1. pii: S0016-5107(21)01847.
    PubMed    


    November 2021
  69. SATO D, Kadota T, Inaba A, Nishihara K, et al
    Long-term clinical outcome after endoscopic resection of esophageal squamous cell carcinoma invading the muscularis mucosae without lymphovascular invasion.
    Gastrointest Endosc. 2021 Nov 10. pii: S0016-5107(21)01781.
    PubMed     Abstract available


  70. FALK GW
    Low-grade dysplasia in Barrett's esophagus: More than meets the eye?
    Gastrointest Endosc. 2021;94:909-911.
    PubMed    


  71. TSOI EH, Mahindra P, Cameron G, Williams R, et al
    Barrett's esophagus with low-grade dysplasia: high rate of upstaging at Barrett's esophagus referral units suggests progression rates may be overestimated.
    Gastrointest Endosc. 2021;94:902-908.
    PubMed     Abstract available


    October 2021
  72. OVERWATER A, van Munster SN, Offerhaus GJA, Seldenrijk CA, et al
    Extension of early esophageal squamous cell neoplasia into ducts and submucosal glands and the role of endoscopic ablation therapy.
    Gastrointest Endosc. 2021;94:832-842.
    PubMed     Abstract available


    September 2021
  73. IWAMURO M, Fujii N, Tanabe S, Okada H, et al
    Desquamative esophagitis followed by esophageal cancer in a stem cell transplant recipient.
    Gastrointest Endosc. 2021 Sep 20. pii: S0016-5107(21)01650.
    PubMed    


  74. FREI NF, Bergman JJGHM, Pouw RE
    Screening for Barrett's esophagus: Ready for prime time or still hard to swallow?
    Gastrointest Endosc. 2021;94:506-508.
    PubMed    


  75. IYER PG, Taylor WR, Slettedahl SW, Lansing RL, et al
    Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett's esophagus in a multisite case-control study.
    Gastrointest Endosc. 2021;94:498-505.
    PubMed     Abstract available


    August 2021
  76. MONTGOMERY EA, Haidry R
    Treating esophageal squamous cell carcinoma with ablation: the fear of what lies beneath.
    Gastrointest Endosc. 2021 Aug 18. pii: S0016-5107(21)01495.
    PubMed    


  77. XIA R, Li H, Shi J, Liu W, et al
    Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study.
    Gastrointest Endosc. 2021 Aug 18. pii: S0016-5107(21)01563.
    PubMed     Abstract available


  78. KAMBOJ AK, Leggett CL
    Barrett's esophagus indefinite for dysplasia carries a definite risk of neoplasia.
    Gastrointest Endosc. 2021;94:271-272.
    PubMed    


  79. DUPREE A, Ehlken H, Rosch T, Luken M, et al
    Laparoscopic lymph node sampling: a new concept for patients with high-risk early esophagogastric junction cancer resected endoscopically.
    Gastrointest Endosc. 2021;94:282-290.
    PubMed     Abstract available


  80. EVERSON MA, Garcia-Peraza-Herrera L, Wang HP, Lee CT, et al
    A clinically interpretable convolutional neural network for the real-time prediction of early squamous cell cancer of the esophagus: comparing diagnostic performance with a panel of expert European and Asian endoscopists.
    Gastrointest Endosc. 2021;94:273-281.
    PubMed     Abstract available


  81. PHILLIPS R, Januszewicz W, Pilonis ND, O'Donovan M, et al
    The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study.
    Gastrointest Endosc. 2021;94:263-270.
    PubMed     Abstract available


    July 2021
  82. YANG LS, Holt BA, Williams R, Norris R, et al
    Endoscopic features of buried Barrett's mucosa.
    Gastrointest Endosc. 2021;94:14-21.
    PubMed     Abstract available


    June 2021
  83. BARTEL MJ, Mousa OY, Brahmbhatt B, Coffman DL, et al
    Impact of topical budesonide on prevention of esophageal stricture after mucosal resection.
    Gastrointest Endosc. 2021;93:1276-1282.
    PubMed     Abstract available


  84. SOLFISBURG QS, Sami SS, Gabre J, Soroush A, et al
    Clinical significance of recurrent gastroesophageal junction intestinal metaplasia after endoscopic eradication of Barrett's esophagus.
    Gastrointest Endosc. 2021;93:1250-1257.
    PubMed     Abstract available


  85. ZHANG M, Zhu C, Wang Y, Kong Z, et al
    Differential diagnosis for esophageal protruded lesions using a deep convolution neural network in endoscopic images.
    Gastrointest Endosc. 2021;93:1261-1272.
    PubMed     Abstract available


    May 2021
  86. MWACHIRO MM, Dawsey SM
    Larger esophageal Lugol's unstained lesions need more follow-up: size as an important predictor for risk of premalignant lesions.
    Gastrointest Endosc. 2021;93:1074-1076.
    PubMed    


  87. DE GROOF J, Antonelli G, Dinis-Ribeiro MJ, Bergman JJ, et al
    Meta-analyses of machine learning in endoscopy: stacking apples and oranges.
    Gastrointest Endosc. 2021;93:1016-1018.
    PubMed    


  88. LIU M, Zhou R, Guo C, Xu R, et al
    Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.
    Gastrointest Endosc. 2021;93:1065-1073.
    PubMed     Abstract available


    April 2021
  89. BABA ER, Uedo N, Rodrigues AL, da Costa Martins B, et al
    "KERATIN PEARLS IN MAGNIFYING ENDOSCOPY OF SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA".
    Gastrointest Endosc. 2021 Apr 22. pii: S0016-5107(21)01313.
    PubMed    


  90. HAIDRY R
    Endoluminal resective therapy for residual esophageal neoplasia after definitive chemoradiotherapy: Who are we helping-the patient or the endoscopist?
    Gastrointest Endosc. 2021;93:899-901.
    PubMed    


  91. SWEI E, Wagh MS
    Endoscopic submucosal dissection in the pharynx: Let's start at the very beginning!
    Gastrointest Endosc. 2021;93:828-830.
    PubMed    


  92. SAPP AR, Wander P, Ali U, Gong Y, et al
    The tongue: an unusual site for esophageal adenocarcinoma metastasis diagnosed with EUS-guided FNA.
    Gastrointest Endosc. 2021;93:977-978.
    PubMed    


  93. KAHN A, Priyan H, Dierkhising RA, Johnson ML, et al
    Outcomes of radiofrequency ablation by manual versus self-sizing circumferential balloon catheters for the treatment of dysplastic Barrett's esophagus: a multicenter comparative cohort study.
    Gastrointest Endosc. 2021;93:880-887.
    PubMed     Abstract available


  94. STRUYVENBERG MR, de Groof AJ, Fonolla R, van der Sommen F, et al
    Prospective development and validation of a volumetric laser endomicroscopy computer algorithm for detection of Barrett's neoplasia.
    Gastrointest Endosc. 2021;93:871-879.
    PubMed     Abstract available


  95. HANADA Y, Wang KK
    Safety and feasibility of same-day discharge after esophageal endoscopic submucosal dissection.
    Gastrointest Endosc. 2021;93:853-860.
    PubMed     Abstract available


  96. IIZUKA T, Kikuchi D, Suzuki Y, Tanaka M, et al
    Clinical relevance of endoscopic treatment for superficial pharyngeal cancer: feasibility of techniques corresponding to each location and long-term outcomes.
    Gastrointest Endosc. 2021;93:818-827.
    PubMed     Abstract available


    March 2021
  97. KAUL V, Diehl D, Enslin S, Infantolino A, et al
    Safety and efficacy of a novel powered endoscopic debridement tissue resection device for management of difficult colon and foregut lesions: first multicenter U.S. experience.
    Gastrointest Endosc. 2021;93:640-646.
    PubMed     Abstract available


    February 2021
  98. DESAI M, Hamade N, Sharma P
    Screening for Barrett's esophagus: challenges in identifying the population at risk.
    Gastrointest Endosc. 2021;93:420-421.
    PubMed    


  99. CHEN Z, Ng H, Liu Y, Guo C, et al
    Endoscopic submucosal dissection of early squamous cell carcinoma of the soft palate.
    Gastrointest Endosc. 2021;93:517-518.
    PubMed    


    January 2021
  100. SUBRAMANIAN SK, Bhakta D, Thosani N
    Hepatocellular carcinoma masquerading as nodular Barrett's esophagus.
    Gastrointest Endosc. 2021 Jan 22. pii: S0016-5107(21)00038.
    PubMed    


  101. MOLENA D, DeMeester SR
    Response.
    Gastrointest Endosc. 2021;93:284-285.
    PubMed    


  102. OTAKI F, Iyer PG
    Response.
    Gastrointest Endosc. 2021;93:283-284.
    PubMed    


  103. STRUYVENBERG MR, de Groof AJ, van der Putten J, van der Sommen F, et al
    A computer-assisted algorithm for narrow-band imaging-based tissue characterization in Barrett's esophagus.
    Gastrointest Endosc. 2021;93:89-98.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.